Sclerosis
Sclerosis
Explore linked clinical trials. Standard reference: MESH:M00195507 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis | Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sclerosis, Skin and Connective Tissue Diseases, connective tissue disorder, diffuse scleroderma, digital ulcers, skin disorder, systemic sclerosis | Recruiting | Not applicable | 2026-09-11 | NCT06256575 | |
| A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sclerosis, Skin and Connective Tissue Diseases, Urogenital Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, dermatomyositis, diffuse scleroderma, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nephritis, nervous system disorder, neuromuscular disease, polymyositis, rheumatic disorder, rheumatoid arthritis, skin disorder, systemic lupus erythematosus, systemic sclerosis, urinary system disorder | Recruiting | Phase 1 | 2026-07-14 | NCT07115745 | |
| A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sclerosis, Skin and Connective Tissue Diseases, Urogenital Diseases, acquired idiopathic inflammatory myopathy, autoimmune disease, connective tissue disorder, dermatomyositis, diffuse scleroderma, glomerulonephritis, immune system disorder, kidney disorder, lupus nephritis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nephritis, nervous system disorder, neuromuscular disease, polymyositis, skin disorder, systemic lupus erythematosus, systemic sclerosis, urinary system disorder | Active, not recruiting | Phase 1 | 2026-01-08 | NCT06255028 | |
| A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD) | Bronchiolitis Obliterans, Digestive System Diseases, Fibrosis, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sclerosis, bronchial disorder, bronchiolitis, bronchiolitis obliterans syndrome, bronchitis, cryptogenic organizing pneumonia, graft versus host disease, immune system disorder, liver disorder, lung disorder, obstructive lung disease, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 2 | 2025-12-15 | NCT06619561 | |
| Physiological Effects of N-Acetyl Cysteine in Patients With Multiple Sclerosis | CNS demyelinating autoimmune disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sclerosis, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Enrolling by invitation | Not applicable | 2025-09-17 | NCT03032601 | |
| Metformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And Neurodegeneration | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Leukoencephalopathies, Nerve Degeneration, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sclerosis, autoimmune disease, autoimmune disorder of the nervous system, brain disorder, central nervous system disorder, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Active, not recruiting | Phase 2 | 2025-06-24 | NCT05893225 | |
| Effects of Individualized Training to Reduce Fatigue in Patients With Newly and Advanced Diagnosed Multiple Sclerosis | Fatigue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sclerosis, Signs and Symptoms | Recruiting | Not applicable | 2024-10-23 | NCT06201026 |